Aetna’s new “level of severity inpatient payment” policy is now set to take effect Jan. 1, 2026, the company recently announced , along with providing additional details about the policy. The policy was supposed to take effect Nov. 15. Aetna earlier this year said it was creating a new type of inpatient reimbursement for so-called “low severity” inpatient stays that it has said will be “comparable” to observation rates. This policy will take the place of Aetna’s (and essentially every other insu

**EDS: THIRD PARTY IMAGE** In this image posted on Nov. 15, 2025, Union Health Minister JP Nadda during the inauguration of ten new AMRIT pharmacy outlets as part of �AMRIT Ka Dasvan Varsh� celebrations at Bharat Mandapam, in New Delhi. (@MoHFW_INDIA/X via PTI Photo)(PTI11_15_2025_000222B) New Delhi: Medicines worth over Rs 17,000 crore at MRP have been dispensed at discounted rates by AMRIT pharmacies so far, resulting in cumulative savings of approximately Rs 8,500 crore for patients, Union He

Indian Pharmacopoeia Commission signs MoU with Jharkhand State Pharmacy Council New Delhi, The Indian Pharmacopoeia Commission (IPC), Ghaziabad, on Saturday inked an MoU with the Jharkhand State Pharmacy Council (JSPC) to promote safe and rational medicine use and strengthen pharmacovigilance in Jharkhand. The Indian Pharmacopoeia Commission (IPC), Ghaziabad, is an autonomous institution under the Union Health Ministry. Through this collaboration, IPC and JSPC will work together to build the cap

KNOXVILLE, Tenn., Nov. 15, 2025 (GLOBE NEWSWIRE) -- Sapphire RX advances digital health accessibility with an innovative telehealth model that prioritizes patient privacy, medical oversight, and personalized care for modern wellness. The company focuses on providing virtual healthcare services with a broader wellness approach, highlighting the importance of secure and accessible care. Redefining Modern Wellness Through Technology Sapphire RX, a U.S.-licensed telehealth provider, is leading t

Welcome back to Endpoints Weekly. It’s going to be a chilly weekend here in Boston, with low temperatures dipping into the 30s — the perfect weather for a warm cup of tea while recapping another busy week in biopharma. If you haven’t already, be sure to read the Endpoints team’s exclusive on how Pfizer closed its deal with Metsera. We also have a feature from Max Gelman on how competition is stacking up in the PD-(L)1xVEGF space, details on Richard Pazdur’s appointment to CDER, some positive res

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Algernon Health Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company, announces the closing of the first tranche (the “First Tranche”) of its non-brokered private placement (the “Offering”), previously announced on November 6, 2025. Gross proceeds from the First Tranche totaled CAD $177,

Scientists identified a small molecule that interrupts a harmful protein pair linked to diabetic inflammation and tissue damage. The compound helped wounds heal faster and reduced organ stress in both Type 1 and Type 2 diabetes models. Unlike typical treatments, it works by blocking damaging signals rather than lowering sugar levels. The results point to a new direction for treating diabetes complications.An experimental compound has been found to limit cell death, reduce inflammation, and lesse

Researchers found that tau proteins don’t jump straight into forming Alzheimer’s-associated fibrils—first they assemble into soft, reversible clusters. When the clusters were dissolved, fibril growth was almost entirely suppressed. This reveals a promising new strategy: stop the precursors, stop the disease.Researchers at Tokyo Metropolitan University have turned to concepts from polymer physics to better understand a central feature of Alzheimer's disease: the formation of tau protein fibrils.

By combining Aurum’s research networks, GHI’s technology infrastructure, and OCI’s computing power, we are establishing a continental engine for translational medicine and future drug development.” — Prof. Vinodh Edward, Group COO of The Aurum Institute WASHINGTON, DC, UNITED STATES, November 14, 2025 / EINPresswire.com / -- IndyGeneUS Bio, a BioFinTech startup redefining how genomic data is owned, monetized, and translated into therapeutics, has partnered with Oracle Cloud Infrastructure (OCI)

WOBURN, Mass., Nov. 14, 2025 /PRNewswire/ -- Micro Medical Solutions (MMS), an innovative medical device company focused on improving outcomes for patients suffering from Critical Limb Threatening Ischemia (CLTI), today announced the appointment of Vince Burgess and John Dahldorf to its Board of Directors. They join George Quinoy, Chairman of the Board and President & Chief Executive Officer, and Dr. Ron Solar, Board Member, as MMS strengthens its leadership team in preparation for commercializa